Why IMU is a multi multi bagger, page-27896

AICp,

I have never gotten a clear answer from anyone (including the IMU investor folks) on why HER-VAXX never seems to get any sort of mention, ever, anywhere.

LC's statements years ago about full dance cards and what seemed to me to be pretty good results should have yielded something. The conclusion on the Horizon study was:
HER-Vaxx plus standard chemotherapy exhibits an excellent safety profile and improves OS. Furthermore, vaccine-induced immune response was significantly associated with reduced tumor size compared with standard-of-care chemotherapy. The presented vaccination approach may substitute for treatment with trastuzumab, upon unavailability or toxicity, based on further evidence of equivalent treatment efficacy.

That looked pretty good to me at the time. And it still does.

I was hoping that IMU would either really press on to remove that 'may' or licence the rights to get someone else onto it who would. I just don't see that happening - although maybe I am missing it.

There are so many useless posts on this thread now - but I am going to tempt fate to ask the few sensible folk on both sides to tell AICp and I what we are missing when we ascribe some value to HER-VAXX?

Possible red rags to bulls - but please don't waste your time or ours unless you really have something knowledgeable to provide by way of answer. Thanks in advance to those who fit the bill and reply.

PS - again tempting fate - but does anyone else find the pipeline/trials section of the IMU website almost impossible to read? If my 9 yearold created that website, I would withhold desert. For a week. It's hopeless.